Literature DB >> 12124990

Assessing the relative importance of the biophysical properties of amino acid substitutions associated with human genetic disease.

Bent N Terp1, David N Cooper, Inge T Christensen, Flemming S Jørgensen, Peter Bross, Niels Gregersen, Michael Krawczak.   

Abstract

The inclusion of a mutation in a pathology-based database such as the Human Gene Mutation Database (HGMD) is a two-stage process: first, the mutation must occur at the DNA level, then it must cause a clinically detectable disease state. The likelihood of the latter step, termed the relative clinical observation likelihood (RCOL), can be regarded as a function of the structural/functional consequences of a mutation at the protein level. Following this paradigm, we modeled in silico all amino acid replacements that could potentially have arisen from an inherited single base pair substitution in five human genes encoding arylsulphatase A (ARSA), antithrombin III (SERPINC1), protein C (PROC), phenylalanine hydroxylase (PAH), and transthyretin (TTR). These proteins were chosen on the basis of 1) the availability of a crystallographic structure, and 2) a sufficiently large number of amino acid replacements being logged in HGMD. A total of 9,795 possible mutant structures were modeled and 20 different biophysical parameters assessed. Together with the HGMD-derived spectra of clinically detected mutations, these data allowed maximum likelihood estimation of RCOL profiles for the 20 parameters studied. Nine parameters (including energy difference between wild-type and mutant structures, accessibility of the mutated residue, and distance from the binding/active site) exhibited statistically significant variability in their RCOL profiles, indicating that mutation-associated changes affected protein function. As yet, however, a biological meaning could only be attributed to the RCOL profiles of solvent accessibility and, for three proteins, local energy change, disturbed geometry, and distance from the active center. The limited ability of the biophysical properties of mutations to explain clinical consequences is probably due to our current lack of understanding as to which amino acid residues are critical for protein folding. However, since the proteins examined here were unrelated, and our findings consistent, it may nevertheless prove possible to extrapolate to other proteins whose dysfunction underlies inherited disease. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12124990     DOI: 10.1002/humu.10095

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  9 in total

Review 1.  Neurovascular Alterations in Alzheimer's Disease: Transporter Expression Profiles and CNS Drug Access.

Authors:  Mitchell P McInerney; Jennifer L Short; Joseph A Nicolazzo
Journal:  AAPS J       Date:  2017-05-01       Impact factor: 4.009

2.  Disease risk of missense mutations using structural inference from predicted function.

Authors:  Jeremy A Horst; Kai Wang; Orapin V Horst; Michael L Cunningham; Ram Samudrala
Journal:  Curr Protein Pept Sci       Date:  2010-11       Impact factor: 3.272

3.  In silico functional profiling of human disease-associated and polymorphic amino acid substitutions.

Authors:  Matthew Mort; Uday S Evani; Vidhya G Krishnan; Kishore K Kamati; Peter H Baenziger; Angshuman Bagchi; Brandon J Peters; Rakesh Sathyesh; Biao Li; Yanan Sun; Bin Xue; Nigam H Shah; Maricel G Kann; David N Cooper; Predrag Radivojac; Sean D Mooney
Journal:  Hum Mutat       Date:  2010-03       Impact factor: 4.878

4.  Spectrum of disease-causing mutations in protein secondary structures.

Authors:  Sofia Khan; Mauno Vihinen
Journal:  BMC Struct Biol       Date:  2007-08-29

5.  Fold designability, distribution, and disease.

Authors:  Philip Wong; Dmitrij Frishman
Journal:  PLoS Comput Biol       Date:  2006-05-05       Impact factor: 4.475

6.  Searching for interpretable rules for disease mutations: a simulated annealing bump hunting strategy.

Authors:  Rui Jiang; Hua Yang; Fengzhu Sun; Ting Chen
Journal:  BMC Bioinformatics       Date:  2006-09-19       Impact factor: 3.169

7.  The amino-acid mutational spectrum of human genetic disease.

Authors:  Dennis Vitkup; Chris Sander; George M Church
Journal:  Genome Biol       Date:  2003-10-30       Impact factor: 13.583

Review 8.  Analysis of genetic variation and potential applications in genome-scale metabolic modeling.

Authors:  João G R Cardoso; Mikael Rørdam Andersen; Markus J Herrgård; Nikolaus Sonnenschein
Journal:  Front Bioeng Biotechnol       Date:  2015-02-16

9.  Use of long term molecular dynamics simulation in predicting cancer associated SNPs.

Authors:  Ambuj Kumar; Rituraj Purohit
Journal:  PLoS Comput Biol       Date:  2014-04-10       Impact factor: 4.475

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.